You are here

Content

Vel. Amet! Duis etiam nisi facilisis mauris lectus. Magna rhoncus! Egestas, mattis pid nunc, dictumst dolor, pid lacus, arcu rhoncus adipiscing augue quis, elementum et aenean. A tristique, cras lacus, ac, purus non adipiscing, tortor nunc dictumst arcu? Ut magnis in mus et eros scelerisque diam! A et a ac lundium purus placerat magna elit tincidunt et, rhoncus.

If a clinical breast exam identifies a breast lump, calcifications that look suspicious are seen on a mammogram, or an ultrasound or MRI identifies an area that looks abnormal, typically the next step is a biopsy.

A biopsy is a sample of cells or tissue. The biopsy is...

DNA HelixIn the past, women seeking genetic testing for breast cancer would be tested solely for the BRCA1 or BRCA2...

MRI

Ultrasound MachineMagnetic resonance imaging (MRI) is a big magnet that takes advantage of the electromagnetic...

Ultrasound MachineUltrasound uses a high-frequency sound wave to create a picture of the inside of the breast. A...

Women often think of mammography as breast cancer prevention. But having an annual mammogram will not keep a woman from getting breast cancer. It can, however, increase a woman's chances of finding breast cancer early.

...

Entering the world of breast cancer treatment can be confusing, scary, and overwhelming. The first thing you need to know is that the type of treatment you will need is determined by your diagnosis. This means it is important to understand what your doctors have found.

...

'Triple negative' is the term used to describe tumors that are ER-negative, PR-negative, and HER2-negative. It's estimated that about 20% of breast tumors are triple...

HER2 also sometimes referred to as HER-2 or Her-2/neu or erb-b2 is one of more than 100,000 genes found in the nucleus of all human cells. The HER2 gene helps cells grow, divide, and repair themselves. Every cell should have only two copies of the HER2 gene. If it has more than two...

Breast tumors are tested to see if they are estrogen receptor (ER) and/or progesterone receptor (PR) positive or negative. Hormone receptor tests are both prognostic and predictive. In general, tumors that are ER+ and/or PR+ are slightly slower growing and have a slightly better...

Lobular carcinoma in situ (LCIS) is a noninvasive precancer. Lobular means that the unusual cells are in the lobules, the parts of the breast capable of making milk. Even though LCIS contains the word carcinoma, which means "cancer," LCIS is not a cancer diagnosis. It is a diagnosis...

Pages